FDA

• 2/3/2025

  Tech Giant’s Forecast Sparks Market Optimism

• 2/2/2025

  Sarepta Shares Plummet: What’s Behind the Tumble?

• 1/31/2025

  Kennedy’s Health Agenda Under Fire

• 1/29/2025

  Healthcare in Turmoil: Cyber Threats and Policy Shifts

• 1/29/2025

  Cancer Breakthrough: Eli Lilly’s $533 Billion Opportunity

• 1/26/2025

  Revolutionizing Depression Treatment: FDA Approves Groundbreaking Nasal Spray

• 1/22/2025

  Evolus Soars: Medical Aesthetics Company Beats Expectations with Strong Q4 Report

• 1/19/2025

  Eli Lilly’s Revenue Outlook Shifts Amidst GLP-1RA Market Volatility

• 1/17/2025

  Moderna’s COVID Vaccine Sales Slump: Revenue Forecast Plummets $1 Billion

• 1/15/2025

  Biotech Giant’s High-Stakes Gamble on In-House Innovation